Advertisement
New Zealand markets closed
  • NZX 50

    12,349.47
    -46.80 (-0.38%)
     
  • NZD/USD

    0.5890
    +0.0001 (+0.01%)
     
  • NZD/EUR

    0.5417
    -0.0009 (-0.16%)
     
  • ALL ORDS

    8,153.40
    +59.10 (+0.73%)
     
  • ASX 200

    7,921.30
    +60.10 (+0.76%)
     
  • OIL

    76.44
    -1.84 (-2.35%)
     
  • GOLD

    2,385.70
    +32.20 (+1.37%)
     
  • NASDAQ

    19,023.66
    +193.07 (+1.03%)
     
  • FTSE

    8,285.71
    +99.36 (+1.21%)
     
  • Dow Jones

    40,589.34
    +654.27 (+1.64%)
     
  • DAX

    18,417.55
    +118.83 (+0.65%)
     
  • Hang Seng

    17,021.31
    +16.34 (+0.10%)
     
  • NIKKEI 225

    37,667.41
    -202.10 (-0.53%)
     
  • NZD/JPY

    90.5250
    -0.0680 (-0.08%)
     

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Want Rising Passive Income? Consider These 2 Stocks for Your Portfolio

Serving more than 100 million customers through its pharmacy benefit manager CVS Caremark and managed care company Aetna, CVS Health (NYSE: CVS) is a company critical to the healthcare sector. It's a safe bet that as long as there is still a need for prescriptions and health insurance, the company will likely do well for its shareholders. This is why analysts believe that CVS Health's non-GAAP (generally accepted accounting principles) adjusted diluted earnings per share (EPS) will compound by 5.9% annually over the next five years.